Debate 2: BRAF Mutant mCRC Patients - Clinical Trial

Filmed on location in New York during the Great Debates and Updates in GI Malignancies 2015, this webcast is part of a series that provides educational discussions on controversial areas in the management of gastrointestinal malignancies. Join us as nationally-recognized thought leaders take opposing sides on topics of clinical interest, and present updates in standards of care.

In this presentation, Dr. Scott Kopetz argues that BRAF mutant metastatic colorectal cancer patients should be enrolled in a clinical trial.

© 2015 Imedex, LLC.